A systematic review of drugs in late-stage development for the treatment of multiple sclerosis: a focus on oral synthetic drugs. Safavi M, Nikfar S, Abdollahi M Inflamm Allergy Drug Targets. 2015 May 28. PMID: 26021323. Abstract CommentRecommendBookmarkWatch